• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events

Insight on Research

A new method to prepare cryo-EM samples avoids protein damage during freezing

Published on 22 October, 2025

Chris Russo’s group in the LMB’s Structural Studies Division, eliminate decades-long problem by preventing protein damage at the air–water interface with high-speed droplet vitrification.

Protein sorting in the Golgi: Should I stay or should I go?

Published on 6 October, 2025

Providing order amongst constant cargo traffic: Sean Munro’s group in the LMB’s Cell Biology Division and John Briggs’ group at the Max Planck Institute of Biochemistry, identify how GOLPH3 enables COPI vesicles to distinguish between Golgi resident and proteins bound for the endoplasmic reticulum.

Syn57 represents a new chapter in the genetic code of life

Published on 1 August, 2025

In a significant rewriting of the genome, Jason Chin’s group in the LMB’s PNAC Division have synthesised E. coli with just 57 codons, freeing seven codons which could be used to introduce non-canonical amino acids and produce novel polymers.

First structure of human telomerase in dimeric assembly

Published on 11 July, 2025

Kelly Nguyen’s group, in the LMB’s Structural Studies Division, have used cryo-EM to visualise telomerase in a dimeric formation for the first time and demonstrated how dimerization is important for telomere maintenance.

How RECQL5 applies the brakes to speeding RNA polymerase II to safeguard genome stability

Published on 7 July, 2025

Suyang Zhang’s group, in the LMB’s Structural Studies Division, has elucidated how the DNA helicase RECQL5 works with the transcription-coupled DNA repair complex to brake and accelerate RNA polymerase II transcription to maintain genome stability.

Architecture of the disease-prone GluA3 receptor unlocks new avenues for drug design

Published on 1 July, 2025

Ingo Greger’s group, in the LMB’s Neurobiology Division, discover that the GluA3 AMPAR adopts a structural organization that substantially diverges from all the other AMPA receptors.

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 63
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed.